Segui
Jiansong Fang
Jiansong Fang
Guangzhou University of Chinese medicine, China; Cleveland Clinic, USA
Email verificata su gzucm.edu.cn - Home page
Titolo
Citata da
Citata da
Anno
Target identification among known drugs by deep learning from heterogeneous networks
X Zeng, S Zhu, W Lu, Z Liu, J Huang, Y Zhou, J Fang, Y Huang, H Guo, ...
Chemical Science 11 (7), 1775-1797, 2020
2402020
A genome-wide positioning systems network algorithm for in silico drug repurposing
F Cheng, W Lu, C Liu, J Fang, Y Hou, DE Handy, R Wang, Y Zhao, ...
Nature communications 10 (1), 3476, 2019
1622019
Deep learning-based prediction of drug-induced cardiotoxicity
C Cai, P Guo, Y Zhou, J Zhou, Q Wang, F Zhang, J Fang, F Cheng
Journal of chemical information and modeling 59 (3), 1073-1084, 2019
1562019
In silico polypharmacology of natural products
J Fang, C Liu, Q Wang, P Lin, F Cheng
Briefings in bioinformatics 19 (6), 1153-1171, 2018
1492018
Comprehensive characterization of protein–protein interactions perturbed by disease mutations
F Cheng, J Zhao, Y Wang, W Lu, Z Liu, Y Zhou, WR Martin, R Wang, ...
Nature genetics 53 (3), 342-353, 2021
1312021
Discovery of multitarget-directed ligands against Alzheimer’s disease through systematic prediction of chemical–protein interactions
J Fang, Y Li, R Liu, X Pang, C Li, R Yang, Y He, W Lian, AL Liu, GH Du
Journal of chemical information and modeling 55 (1), 149-164, 2015
1222015
Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment
J Fang, L Wang, T Wu, C Yang, L Gao, H Cai, J Liu, S Fang, Y Chen, ...
Journal of ethnopharmacology 196, 281-292, 2017
1162017
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease
J Fang, P Zhang, Y Zhou, CW Chiang, J Tan, Y Hou, S Stauffer, L Li, ...
Nature Aging 1 (12), 1175-1188, 2021
1112021
Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation
L Gao, K Wang, Y Zhou, J Fang, X Qin, G Du
Scientific reports 8 (1), 624, 2018
1052018
Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery
J Fang, R Yang, L Gao, D Zhou, S Yang, A Liu, G Du
Journal of chemical information and modeling 53 (11), 3009-3020, 2013
1002013
Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug–Target Interactions of Natural Products Enables New Targeted Cancer Therapy
J Fang, Z Wu, C Cai, Q Wang, Y Tang, F Cheng
Journal of chemical information and modeling 57 (11), 2657-2671, 2017
782017
Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation
J Fang, P Wu, R Yang, L Gao, C Li, D Wang, S Wu, AL Liu, GH Du
Acta Pharmaceutica Sinica B 4 (6), 430-437, 2014
772014
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
J Fang, AA Pieper, R Nussinov, G Lee, L Bekris, JB Leverenz, ...
Medicinal research reviews 40 (6), 2386-2426, 2020
622020
A systems pharmacology approach uncovers wogonoside as an angiogenesis inhibitor of triple-negative breast cancer by targeting hedgehog signaling
Y Huang, J Fang, W Lu, Z Wang, Q Wang, Y Hou, X Jiang, O Reizes, ...
Cell chemical biology 26 (8), 1143-1158. e6, 2019
622019
DeepScreening: a deep learning-based screening web server for accelerating drug discovery
Z Liu, J Du, J Fang, Y Yin, G Xu, L Xie
Database 2019, baz104, 2019
602019
Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mice
T Hu, JJ Shi, J Fang, Q Wang, YB Chen, SJ Zhang
Aging (Albany NY) 12 (8), 7015, 2020
562020
Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice
HY Li, XC Wang, YM Xu, NC Luo, S Luo, XY Hao, SY Cheng, JS Fang, ...
Rejuvenation Research 21 (3), 200-209, 2018
552018
Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease
P Xiao-Cong, K De, F Jian-Song, Z Ying, XU Lv-Jie, L Wen-Wen, ...
Chinese Journal of Natural Medicines 16 (1), 53-62, 2018
552018
Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: a microarray study
L Gao, C Li, RY Yang, WW Lian, JS Fang, XC Pang, XM Qin, AL Liu, ...
Pharmacology Biochemistry and Behavior 133, 155-163, 2015
542015
The mechanisms of Bushen-Yizhi formula as a therapeutic agent against Alzheimer’s disease
H Cai, Y Luo, X Yan, P Ding, Y Huang, S Fang, R Zhang, Y Chen, Z Guo, ...
Scientific Reports 8 (1), 3104, 2018
522018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20